Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

ClinicalTrials.gov ID: NCT05432167

Public ClinicalTrials.gov record NCT05432167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney Disease (CKD).

Study identification

NCT ID
NCT05432167
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
195 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 29, 2022 (Actual)
Primary completion
May 2, 2024 (Actual)
Completion
May 2, 2024 (Actual)
Last update posted
May 20, 2025

2022 – 2024

United States locations

U.S. sites
71
U.S. states
28
U.S. cities
68
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Huntsville Alabama 35805 —
Research Site Beverly Hills California 90211 —
Research Site Chula Vista California 91910 —
Research Site Fountain Valley California 92708 —
Research Site Granada Hills California 91344 —
Research Site Lancaster California 93534 —
Research Site Lincoln California 95648 —
Research Site Los Angeles California 90010 —
Research Site Lynwood California 90262 —
Research Site Northridge California 91324 —
Research Site Panorama City California 91402 —
Research Site Pomona California 91767 —
Research Site Rancho Cucamonga California 91730 —
Research Site Riverside California 92503 —
Research Site San Dimas California 91773 —
Research Site South Gate California 90280 —
Research Site Tarzana California 91356 —
Research Site Vacaville California 95687 —
Research Site Victorville California 92392 —
Research Site Arvada Colorado 80002 —
Research Site Littleton Colorado 80120 —
Research Site Hollywood Florida 33021 —
Research Site Orlando Florida 32807 —
Research Site Orlando Florida 32808 —
Research Site Tampa Florida 33612 —
Research Site West Palm Beach Florida 33401 —
Research Site Columbus Georgia 31904 —
Research Site Decatur Georgia 30030 —
Research Site Nampa Idaho 83687 —
Research Site Chicago Illinois 60643 —
Research Site Brownsburg Indiana 46112 —
Research Site Lexington Kentucky 40503 —
Research Site Metairie Louisiana 70006 —
Research Site Monroe Louisiana 71201 —
Research Site Silver Spring Maryland 20904 —
Research Site New Bedford Massachusetts 02740 —
Research Site Flint Michigan 48504 —
Research Site Flint Michigan 48532 —
Research Site Troy Michigan 48085 —
Research Site Olive Branch Mississippi 38654 —
Research Site Kansas City Missouri 64111 —
Research Site Trenton New Jersey 08611 —
Research Site The Bronx New York 10455 —
Research Site Durham North Carolina 27704 —
Research Site Greenville North Carolina 27834 —
Research Site Kinston North Carolina 28504 —
Research Site Morganton North Carolina 28655 —
Research Site Oxford North Carolina 27565 —
Research Site Wilmington North Carolina 28401 —
Research Site Cincinnati Ohio 45246 —
Research Site Bethany Oklahoma 73008 —
Research Site Scottdale Pennsylvania 15683 —
Research Site Smithfield Pennsylvania 15478 —
Research Site Providence Rhode Island 02903 —
Research Site Memphis Tennessee 38119 —
Research Site Houston Texas 77099 —
Research Site Lampasas Texas 76550 —
Research Site Paris Texas 75462 —
Research Site Red Oak Texas 75154 —
Research Site San Antonio Texas 78212 —
Research Site San Antonio Texas 78249 —
Research Site Salt Lake City Utah 84132 —
Research Site Burlington Vermont 05401 —
Research Site Alexandria Virginia 22304 —
Research Site Burke Virginia 22015 —
Research Site Charlottesville Virginia 22908 —
Research Site Manassas Virginia 20110 —
Research Site Newport News Virginia 23606 —
Research Site Salem Virginia 24153 —
Research Site Kingwood West Virginia 26537 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05432167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2025 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05432167 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →